Petros Family Wealth LLC Invests $205,000 in Solventum Co. (NYSE:SOLV)

Petros Family Wealth LLC purchased a new stake in shares of Solventum Co. (NYSE:SOLV) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 3,098 shares of the company’s stock, valued at approximately $205,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in SOLV. Modus Advisors LLC acquired a new position in shares of Solventum in the 4th quarter valued at approximately $25,000. Stonebridge Financial Group LLC bought a new stake in shares of Solventum in the fourth quarter worth $26,000. Crews Bank & Trust acquired a new stake in Solventum in the fourth quarter valued at $32,000. Synergy Asset Management LLC bought a new position in Solventum during the 4th quarter valued at $35,000. Finally, Spire Wealth Management acquired a new position in Solventum during the 4th quarter worth $37,000.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on SOLV. Wells Fargo & Company increased their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. The Goldman Sachs Group increased their target price on Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a report on Monday, March 3rd. Mizuho boosted their price target on Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. Bank of America raised their price objective on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 26th. Finally, Morgan Stanley boosted their target price on shares of Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $79.86.

Solventum Price Performance

Shares of SOLV opened at $66.19 on Friday. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The stock has a fifty day moving average price of $74.19 and a 200 day moving average price of $71.70. The company has a market cap of $11.45 billion and a P/E ratio of 24.07.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.